Health News Archive - December 20, 2005
Worried about how to succeed in life? Don't worry, be happy. That's the take-home message from a major new review of studies on the downstream benefits of personal happiness.
CHICAGO (Reuters) - Popular anti-heartburn drugs such as proton-pump inhibitors that block stomach acid production heighten the risk of an increasingly common infectious form of diarrhea, researchers said on Monday.
As the holiday shopping season draws to a close, experts are urging parents to carefully screen the toys their children receive this year and assess their safety.
NEW YORK (Reuters Health) - Behavioral and nutritional counseling improves energy intake and promotes normal growth in toddlers and preschoolers with cystic fibrosis (CF), according to results of a small study.
China and the United States are cooperating on efforts to understand deadly bird flu, a major shift from Beijing's handling of SARS, U.S. National Institutes of Health director Elias Zerhouni said on Tuesday.
By Lara Brenckle, The Centre Daily Times, State College, Pa., The Centre Daily Times, State College, Pa. Dec. 20--BELLEFONTE -- Four people charged with helping distribute $1.5 million worth of heroin and cocaine in Centre County pleaded guilty to drug and criminal conspiracy charges Monday.
By Troy Graham, The Philadelphia Inquirer, The Philadelphia Inquirer Dec.
By Amy Norton NEW YORK (Reuters Health) - A relatively rare heart condition that has been linked to athletes' deaths can arise anywhere from childhood to well into middle age, and its first symptoms range from heart palpitations to sudden death, a new study shows.
NEW YORK (Reuters Health) - Age has no effect on outcome after implantation of a cochlear device among people over 65, a study suggests, leading researchers to conclude that elderly patients "should not be discriminated against in assessments for cochlear implant candidacy." A cochlear implant is a small electronic device that can help to provide a sense of sound to a person who is profoundly deaf or severely hard of hearing.
WASHINGTON (Reuters) - German drugmaker Bayer AG won U.S. approval to sell its oral drug Nexavar for treating adults with the most common type of kidney cancer, the Food and Drug Administration said on Tuesday.